软件服务

Search documents
芯原股份20250825
2025-08-25 09:13
芯原股份 20250825 摘要 新元股份 2025 年上半年销售额同比增长 50%,订单总额达 20 亿元, 连续 7 个季度创新高,主要来自一站式服务,占比超 90%,显示业务模 式的市场认可度和可持续增长潜力。 公司新签订单在过去一年内达 11.82 亿,单季环比增长 150%,IP 业务 显著增长,数字 IP 中的 GPU、MPU、VPU 占据 75%份额,设计服务收 入中 AI 算力相关部分占 52%,先进工艺占比高。 2025 年上半年,量产业务收入超 4 亿,同比增长 24%,二季度环比增 长 79%,同比增长 11%。公司无库存压力,产品多样,新签订单金额 超 7 亿,环比增长 700%,同比增长 350%。 公司客户结构分散,系统公司、互联网公司、云服务公司及车企直接定 制业务占比达 35.66%,上半年新增客户 450 家,一站式服务客户 340 家,市场覆盖面扩大。 上半年综合毛利率为 43.32%,设计服务和量产业务毛利率较低,但因 前期投入少、无库存风险,毛利即为净利。公司整体尚未盈利,但亏损 幅度大幅收窄至 54.84%。 Q&A 新元股份在 2025 年上半年的业绩表现如何? 在 ...
美股市场速览:回调后再度发动,中小盘明显占优
Guoxin Securities· 2025-08-24 09:03
2025年08月24日 证券研究报告 | 美股市场速览 回调后再度发动,中小盘明显占优 行业研究·海外市场专题 美股 弱于大市·维持 证券分析师:王学恒 证券分析师:张熙,CFA 010-88005382 0755-81982090 wangxueh@guosen.com.cn zhangxi4@guosen.com.cn S0980514030002 S0980522040001 请务必阅读正文之后的免责声明及其项下所有内容 数据速览 价格走势:回调后再度发动,中小盘明显占优 资金流向:整体流入接近停滞,行业间分化较大 本周,标普500成分股估算资金流(涨跌额 x 成交量)为+1.7(亿美元,下同),上周为+75.8,近4周为-75.0,近13周为+209.2。 18个行业资金流入,6个行业资金流出。资金流入的行业有:汽车与汽车零部件(+11.0)、综合金融(+4.6)、银行(+3.8)、资本品(+3.3)、医疗保健设备 与服务(+3.3);资金流出的行业主要有:软件与服务(-29.9)、半导体产品与设备(-7.7)、食品与主要用品零售(-4.7)、技术硬件与设备(-2.3)、媒 体与娱乐(-1.1)。 盈 ...
亚辉龙收盘下跌1.54%,滚动市盈率35.74倍,总市值87.79亿元
Sou Hu Cai Jing· 2025-08-19 12:05
8月19日,亚辉龙今日收盘15.39元,下跌1.54%,滚动市盈率PE(当前股价与前四季度每股收益总和的 比值)达到35.74倍,总市值87.79亿元。 从行业市盈率排名来看,公司所处的医疗器械行业市盈率平均59.49倍,行业中值40.19倍,亚辉龙排名 第69位。 股东方面,截至2025年3月31日,亚辉龙股东户数12415户,较上次增加285户,户均持股市值35.28万 元,户均持股数量2.76万股。 深圳市亚辉龙生物科技股份有限公司的主营业务是以化学发光免疫分析法为主的体外诊断仪器及配套试 剂的研发、生产和销售,及部分非自产医疗器械产品的代理销售业务。公司的主要产品是自产试剂(非 新冠产品)、自产仪器(非新冠产品)、自产耗材(非新冠产品)、自产新冠产品、软件服务、代理试 剂、代理仪器、代理耗材。公司自主研发了磁微粒吖啶酯直接化学发光免疫诊断技术,研制了包括仪器 和配套试剂在内的全自动免疫分析系统,打破了国外巨头在吖啶酯直接发光领域的技术垄断,成为国内 较早实现磁微粒吖啶酯化学发光免疫分析仪及配套试剂产业化的企业,填补了国内市场空白。公司质量 体系建设达到国际标准,主要产品已通过ISO9001认证、ISO ...
ST华通:公司及其控股子公司担保额度总金额约为80.74亿元
Sou Hu Cai Jing· 2025-08-15 14:19
Group 1 - ST Huaton announced on August 15 that it will provide a guarantee for its wholly-owned subsidiary, Lansha Information, which plans to apply for a credit limit of up to 1 billion RMB from Beijing Bank Shanghai Branch [1] - The guarantee amount provided by the company will not exceed 200 million RMB, with a guarantee period lasting three years from the date of borrowing [1] - After this guarantee, the total guarantee amount for the company and its subsidiaries will be approximately 8.074 billion RMB, with the total external guarantee balance being about 5.017 billion RMB, accounting for 20.22% of the company's latest audited net assets [1] Group 2 - In the fiscal year 2024, ST Huaton's revenue composition is as follows: software services 92.69%, automotive parts 7.2%, artificial intelligence cloud data 0.08%, and other industries 0.03% [1] - As of the report date, ST Huaton's market capitalization is 100.2 billion RMB [2]
ST华通:8月15日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-15 14:18
Group 1 - ST Huaton (SZ 002602) announced the convening of its sixth board meeting on August 15, 2025, in Shanghai, combining in-person and remote voting methods [2] - The meeting reviewed the proposal to hold the third extraordinary general meeting of shareholders in 2025 [2] - For the year 2024, ST Huaton's revenue composition was as follows: software services accounted for 92.69%, automotive parts for 7.2%, artificial intelligence cloud data for 0.08%, and other industries for 0.03% [2]
亚辉龙收盘上涨1.44%,滚动市盈率36.02倍,总市值88.47亿元
Sou Hu Cai Jing· 2025-08-15 12:46
Company Overview - Shenzhen Aihuilong Biotechnology Co., Ltd. specializes in the research, production, and sales of in vitro diagnostic instruments and related reagents, primarily using chemiluminescence immunoassay technology [2] - The company has developed a fully automated immunoassay system, breaking the technological monopoly of foreign giants in the field of acridine ester chemiluminescence [2] - Aihuilong's quality management system meets international standards, with major products certified by ISO9001, ISO13485, and EU CE [2] Financial Performance - For Q1 2025, the company reported revenue of 418 million yuan, a year-on-year decrease of 3.13%, and a net profit of 10.148 million yuan, down 84.63% year-on-year [2] - The sales gross margin stood at 59.49% [2] Market Position - As of August 15, Aihuilong's stock closed at 15.51 yuan, with a rolling PE ratio of 36.02, and a total market capitalization of 8.847 billion yuan [1] - The average PE ratio in the medical device industry is 56.58, with a median of 39.97, placing Aihuilong at the 70th position in the industry ranking [1][3] - The company has one institutional holder, with a total holding of 0.14 thousand shares, valued at 0.00 billion yuan [1]
ST华通:公司及其控股子公司担保额度总金额约78.74亿元
Mei Ri Jing Ji Xin Wen· 2025-08-15 11:41
Group 1 - The company and its subsidiaries have a total guarantee amount of approximately 7.874 billion yuan, with an external guarantee balance of about 5.067 billion yuan, accounting for 20.42% of the latest audited net assets [1] - The guarantees provided to entities outside the consolidated financial statements amount to approximately 2.635 billion yuan, representing 10.62% of the latest audited net assets [1] - In the fiscal year 2024, the revenue composition of ST Huayun is as follows: software services account for 92.69%, automotive parts for 7.2%, artificial intelligence cloud data for 0.08%, and other industries for 0.03% [1] Group 2 - ST Huayun announced plans to engage in factoring business with financial institutions to meet the funding needs of its wholly-owned subsidiary Chengdu Youji Technology Co., Ltd., applying for a total credit limit of up to 300 million yuan from Dalian Bank Shanghai Branch [3] - The credit limit includes an exposure limit of 150 million yuan, which will be shared between the company and its subsidiary [3] - The company will sign a "Buyer Lianxintong" factoring agreement and a tripartite cooperation agreement with relevant platforms to utilize the credit limit [3]
华泰证券:战术关注景气改善的低位补涨品种,战略看好大金融、医药、军 工
Sou Hu Cai Jing· 2025-08-10 23:45
Group 1 - The A-share market experienced a rebound driven by trading funds, with a notable increase in volatility expectations and a return to a "dumbbell" style focusing on dividends and small-cap stocks [1][2] - The margin trading balance reached a nearly 10-year high of 2 trillion yuan, indicating significant liquidity support for the market [2][3] - The number of public fund reports has shown signs of recovery, suggesting a potential shift of household savings into equity funds [2][3] Group 2 - The "anti-involution" policy is beginning to show results, with July's PPI year-on-year expected to rebound from its low point, although the extent of recovery will depend on policy effectiveness [3][4] - The macroeconomic indicators, such as improved profit margins for industrial enterprises and reduced accounts receivable turnover days, reflect positive impacts from the "anti-involution" measures [3][4] - Certain sectors, including wind power, automotive, logistics, and aquaculture, are experiencing a recovery in sentiment, indicating a broader improvement in economic conditions [3][4] Group 3 - External risks remain, particularly regarding tariff policies and Federal Reserve monetary policy, which could affect market sentiment and investment strategies [4][5] - The market is approaching a period of concentrated interim report disclosures, which may lead to increased volatility, but the downside risk is considered limited [5][6] - Tactical investment strategies are recommended to focus on sectors with improving sentiment and potential for rebound, such as storage, software, and certain chemical products [5][6]
Onestream (OS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-08-08 00:01
Core Viewpoint - Onestream reported stable revenue for Q2 2025, with a notable EPS increase, indicating potential resilience in financial performance despite market challenges [1]. Financial Performance - Revenue for the quarter ended June 2025 was $147.59 million, unchanged from the previous year, and exceeded the Zacks Consensus Estimate of $140.97 million by 4.7% [1]. - EPS for the quarter was $0.05, a significant increase from $0 in the same quarter last year, resulting in a surprise of 400% compared to the consensus estimate of $0.01 [1]. Key Metrics - The company had 1,600 customers, slightly below the average estimate of 1,692 by two analysts [4]. - Subscription revenue was $133.63 million, surpassing the average estimate of $128.96 million from five analysts [4]. - Professional services and other revenue reached $8 million, exceeding the average estimate of $7.04 million from six analysts [4]. - License revenue was reported at $5.96 million, above the average estimate of $4.75 million from five analysts [4]. - Gross profit from software was $105.3 million, compared to the average estimate of $102.09 million based on four analysts [4]. - Gross profit from professional services and other was -$4.1 million, worse than the average estimate of -$2.4 million based on four analysts [4]. Stock Performance - Over the past month, Onestream's shares have returned -9.5%, contrasting with the Zacks S&P 500 composite's +1.2% change [3]. - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3].
拓维信息股价微跌0.09% 股东户数较上期减少12.38%
Jin Rong Jie· 2025-08-05 18:05
Group 1 - The stock price of Tuowei Information as of August 5, 2025, closed at 32.03 yuan, a decrease of 0.03 yuan or 0.09% from the previous trading day [1] - The trading volume on that day was 593,900 hands, with a transaction amount of 1.891 billion yuan [1] - As of July 31, 2025, the number of shareholders for Tuowei Information was 453,800, a decrease of 64,100 or 12.38% from the previous period [1] Group 2 - The average number of circulating shares held by each shareholder increased from 2,201 shares to 2,526 shares, with an average circulating market value of 82,000 yuan [1] - As of July 31, 2025, the number of shares held by the Shenzhen Stock Connect was 4.7083 million shares, accounting for 0.37% of the circulating share capital, a decrease of 81.37% from the previous period [1] - On August 5, 2025, the net outflow of main funds was 73.8302 million yuan, accounting for 0.2% of the circulating market value [1]